Literature DB >> 10229302

Type 2 diabetes mellitus, cognitive impairment and dementia.

R Stewart1, D Liolitsa.   

Abstract

AIMS: We set out to examine the evidence for an association between cognitive impairment or dementia and the presence of Type 2 diabetes mellitus (DM). We also sought evidence of potential mechanisms for such an association.
METHODS: A literature search of three databases was performed and the reference lists of the papers so identified were examined, using English language papers only.
RESULTS: We found evidence of cross-sectional and prospective associations between Type 2 DM and cognitive impairment, probably both for memory and executive function. There is also evidence for an elevated risk of both vascular dementia and Alzheimer's disease in Type 2 DM albeit with strong interaction of other factors such as hypertension, dyslipidaemia and apolipoprotein E phenotype. Both vascular and non-vascular factors are likely to play a role in dementia in diabetes.
CONCLUSIONS: Current classification structures for dementia may not be adequate in diabetes, where mixed pathogenesis is likely. Further research into the mechanisms of cognitive impairment in Type 2 DM may allow us to challenge the concept of dementia, at least in these patients, as an irremediable disease.

Entities:  

Mesh:

Year:  1999        PMID: 10229302     DOI: 10.1046/j.1464-5491.1999.00027.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  125 in total

1.  [Diabetes and dementia].

Authors:  A Bahrmann; P Bahrmann; T Kubiak; D Kopf; P Oster; C C Sieber; W G Daniel
Journal:  Z Gerontol Geriatr       Date:  2012-01-27       Impact factor: 1.281

Review 2.  Central nervous system involvement in diabetes mellitus.

Authors:  Dinesh Selvarajah; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

3.  Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic.

Authors:  Geert Jan Biessels; Aafke Koffeman; Philip Scheltens
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

4.  Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studies.

Authors:  Pravat K Mandal; Jay W Pettegrew; Dennish W McKeag; Ratna Mandal
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

5.  Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey.

Authors:  Jaana Suvisaari; Jonna Perälä; Samuli I Saarni; Tommi Härkänen; Sami Pirkola; Matti Joukamaa; Seppo Koskinen; Jouko Lönnqvist; Antti Reunanen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

Review 6.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 7.  Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus.

Authors:  Amy S Shah; Elaine M Urbina
Journal:  Curr Diab Rep       Date:  2017-06       Impact factor: 4.810

8.  Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes.

Authors:  Ashley L Fischer; Cindy M de Frias; Sophie E Yeung; Roger A Dixon
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

9.  Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly.

Authors:  Antonio Convit; Oliver T Wolf; Chaim Tarshish; Mony J de Leon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

Review 10.  The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research.

Authors:  David E Vance; Pariya L Fazeli; Joan E Dodson; Michelle Ackerman; Michele Talley; Susan J Appel
Journal:  J Neurosci Nurs       Date:  2014-10       Impact factor: 1.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.